Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has reported a 9.99% beneficial ownership in Silo Pharma, Inc. (SILO) as of June 30, 2026. This ownership, totaling 125,261 shares, is derived entirely from the exercise of warrants and is capped …